IN BRIEF: Tiziana Life Sciences annual loss widens

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious ...

Alliance News 18 May, 2021 | 8:38PM
Email Form Facebook Twitter LinkedIn RSS

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Pretax loss in 2020 widens to GBP22.1 million from GBP7.8 million. Widened loss partly down to company paying GBP10.3 million in realisation bonus, compared to no such costs in 2019.

Current stock price: 71.99 pence, down 5.2% on Tuesday

Year-to-date change: down 21%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Tiziana Life Sciences PLC

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures